Is it time for in silico simulation of drug cardiac side effects?

Annals of the New York Academy of Sciences

Volumn 1245, Issue 1, 2011, Pages 44-47

  Mirams, Gary R ^a   Noble, Denis ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cardiac toxicity; Computer modeling; HERG; Torsade de pointes

Indexed keywords

POTASSIUM CHANNEL HERG; RANOLAZINE; VERAPAMIL;

ARTICLE; CARDIOTOXICITY; DRUG SAFETY; ELECTROPHYSIOLOGY; NONHUMAN; QT PROLONGATION; RISK ASSESSMENT; SIMULATION; TORSADE DES POINTES;

ANIMALIA;

EID: 84855221252     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06324.x     Document Type: Article

References (10)

1. Corrias, A. et al. 2010. Arrhythmic risk biomarkers for the assessment of drug cardiotoxicity: from experiments to computer simulations. Philos. Transact. A. Math. Phys. Eng. Sci. 368: 3001-3025.
2. Pollard, C.E. et al 2010. An introduction to QT interval prolongation and non-clinical approaches to assessing and reducing risk. Br. J. Pharmacol. 159: 12-21.
3. Straus, S.M.J.M. et al 2005. Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur. Heart. J. 26: 2007-2012.
4. Redfern, W.S. et al 2003. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc. Res. 58: 32-45.
5. Noble, D. & Y. Rudy 2001. Models of cardiac ventricular action potentials: iterative interaction between experiment and simulation. Philos. Transact. A. Math. Phys. Eng. Sci. 359: 1127-1142.
6. Noble, D. & P.J. Noble 2006. Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload. Heart 92: 1-5.
7. Mirams, G.R. et al 2011. Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk. Cardiovas. Res. 91: 53-61.
8. Fletcher, K. et al 2011. Novel approaches to assessing cardiac safety-proceedings of a workshop: regulators, industry and academia discuss the future of in silico cardiac modelling to predict the proarrhythmic safety of drugs. Drug Safety 34: 439-443.
9. Cooper, J., G.R. Mirams & S. Niederer 2011. High throughput functional curation of cellular models. Prog. Biophys. Mol. Biol. 107: 11-20.
10. Pitt-Francis, J. et al 2009. Chaste: a test-driven approach to software development for biological modelling. Comput. Phys. Commun. 180: 2452-2471.